Watch MPT. Know when insiders buy.
One email the day a filing lands. Free.
Work order
53
WATCH · insiders 55, shorts 50
Insiders, 90 days
+$10K
net buying · 1 buy, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.4BP/E —DIV YIELD 8.48%FCF YIELD —REV TTM $1B +5.5%NET INCOME −$125.9MNET DEBT $9.2B52W 3.97 – 6.02NEXT EARNINGS Oct 29SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2026 · Mar 31 | $252.1M | +12.6% | 61.4% | — | $32.8M | — | 0.05 | −$14.3M | — | — | May 8 |
| Q4 2025 · Dec 31derived | $270.3M | +16.6% | 95.8% | — | $17.3M | — | 0.03 | $160.1M | — | — | Feb 26 |
| Q3 2025 · Sep 30 | $237.5M | +5.2% | 109.4% | — | −$77.7M | — | -0.13 | $18.6M | — | — | Nov 7 |
| Q2 2025 · Jun 30 | $240.4M | −9.8% | 91.8% | — | −$98.4M | — | -0.16 | $51.7M | — | — | Nov 7 |
| Q1 2025 · Mar 31 | $223.8M | −17.5% | 63.6% | — | −$118.3M | — | -0.20 | $384K | — | — | May 8 |
| Q4 2024 · Dec 31derived | $231.8M | — | 90.9% | — | −$412.8M | — | -0.69 | $76.7M | — | — | Feb 26 |
| Q3 2024 · Sep 30 | $225.8M | −26.3% | 96.5% | — | −$801.2M | −786.5% | -1.34 | $59.2M | — | — | Nov 7 |
| Q2 2024 · Jun 30 | $266.6M | −21.0% | 98.4% | — | −$320.6M | — | -0.54 | $35.3M | — | — | Nov 7 |
| Q1 2024 · Mar 31 | $271.3M | — | 84.9% | — | −$875.6M | — | -1.46 | $74.3M | — | — | May 9 |
| Q4 2023 · Dec 31derived | −$122.4M | — | 41.1% | — | −$663.9M | — | -1.11 | $135.4M | — | — | Feb 26 |
| Q3 2023 · Sep 30 | $306.6M | — | 90.6% | — | $116.7M | — | 0.19 | $158.2M | — | — | Nov 12 |
| Q2 2023 · Jun 30 | $337.4M | — | 108.5% | — | −$42M | — | -0.07 | $76.5M | — | — | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $972M | 90.7% | — | −$277M | -28.5% | -0.46 | $230.8M | — | — | $23.4M | — |
| FY2024 · to Dec 31 | $995.5M | 92.6% | — | −$2.4B | -242.1% | -4.02 | $245.5M | — | — | — | — |
| FY2023 · to Dec 31 | $871.8M | 87.4% | — | −$556.5M | -63.8% | -0.93 | $505.8M | — | — | — | — |
| FY2022 · to Dec 31 | $1.5B | 89.1% | — | $902.6M | 58.5% | 1.50 | $739M | — | — | $17.9M | — |
| FY2021 · to Dec 31 | $1.5B | 93.4% | — | $656M | 42.5% | 1.11 | $811.7M | — | — | — | — |
| FY2020 · to Dec 31 | $1.2B | 97.6% | — | $431.4M | 34.5% | 0.81 | $617.6M | — | — | — | — |
Every number comes from MEDICAL PROPERTIES TRUST INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.